ResearchHealthcare › AORT
Back to Dashboard

AORT

Artivion, Inc.
Healthcare · Medical Devices
$24.31
Market cap $1.2B

Price Chart

Composite ScoreAbove average
53.0Score
FF5
58
MF
22
PIO
78
QARP
50
CG
3
CV
12
Intrinsic ValueModel estimate
$5.05
381% above the model

A discounted-cash-flow and earnings-power estimate, not a price target. It is the least certain number on this page and it disagrees with the market more often than it agrees — treat a wide gap as a question to go and answer, not an answer.

Factor Profile
FF5PIOQARPMFCVCG
Where AORT sits · all 2,442 covered names
AORT 53.0050100

Ranks 1,096 of 2,442 — the 55.1th percentile, and 204 of 437 within Healthcare.

Sector Outlook — Healthcare
Pro · locked

Overweight / neutral / underweight call for Healthcare, with conviction, catalysts and risks from our sector deep-research panel.

Upgrade to Pro to unlock sector outlooks →
Analyzing sector peers…

Latest News — AORT

Options-Implied

The market's own forecast: implied move into earnings, skew, and how today's implied volatility compares with what actually happened the last eight times this name reported.

Create a free account →

The score is free. What changes is the product.

Every number above stays free and needs no account. What we sell is the delta — the day a model changes its reading, the research behind the change, and the book we run on it.

Rating-change alerts

Tell me the day any model changes its reading on AORT. The score is a snapshot; the change is the signal.

Pre-trade research

The full note behind the number — what the models are reacting to, and what would break the case.

The tracked book

Our own 15-name portfolio, marked daily against the S&P 500 since inception. Every position public.

Peers & sector

AORT against every name in Healthcare, on every model at once.

Free daily briefing, no card. We’ll tell you when per-ticker rating-change alerts open. Unsubscribe in one click.

Sanctuary Research publishes quantitative investment research and educational content. Nothing here is personalised investment advice, and a model score is not a recommendation to buy or sell. Markets involve risk; do your own due diligence. Scores as of 2026-08-11.